Li-Huei Tsai receives The Hans Wigzell Research Foundation's science prize amounting to USD 100,000
The Hans Wigzell Research Foundation (Hans Wigzells forskningsstiftelse) will today award its third annual scientific prize to the neuroscientist Professor Li-Huei Tsai at Massachusetts Institute of Technology (MIT) in Cambridge, USA. Professor Tsai is to receive the prize of USD 100,000 for her pioneering research on the causes and possible therapy of Alzheimer's disease.
The research, carried out at Picower Institute for Learning and Memory Department of Brain and Cognitive Sciences Massachusetts Institute of Technology has rapidly resulted in ongoing, advanced clinical trials on Alzheimer's patients, and has attracted considerable interest in the medical world.
Part of the foundation's citation reads:
"Professor Li-Huei Tsai at MIT has made a number of impressive findings in Alzheimer's disease. In her research she has been involved in developing completely new methods that, through selective light stimulation in animal experiments, have been able to cause Alzheimer's disease mice to drastically improve in their disease."
Rhenman & Partners Asset Management is the initiator and founder of the research foundation.
For more information, please contact:
Hans Wigzells Forskningsstiftelse
E-mail: hw@forskningsstiftelse.se
About Li-Huei Tsai
Professor and Director of Picower Institute for Learning and Memory Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology
Li-Huei Tsai received her Ph.D degree from the University of Texas Southwestern Medical Center at Dallas. Dr. Tsai completed her postdoctoral work with Ed Harlow’s laboratory at Cold Spring Harbor laboratory and Massachusetts General Hospital. In 1994, Dr. Tsai joined the faculty in the Department of Pathology at Harvard Medical School and was named an investigator of Howard Hughes Medical Institute in 1997. In 2006, she was appointed Professor in the Department of Brain and Cognitive Sciences, and joined the Picower Institute for Learning and Memory at MIT. In 2015, she co-founded the Aging Brain Initiative at MIT.
About Hans Wigzell
Professor of Immunology, Karolinska Institutet
Former President of Karolinska Institutet, Chairman of KI’s Nobel Committee, Director General of the Infectious Diseases Institute and National Bacteriological Laboratory. Hans Wigzell is also a member of the Royal Swedish Academy of Sciences and the Royal Swedish Academy of Engineering Sciences IVA.
About the Hans Wigzell Research Foundation
The foundation promotes its support of scientific research and education in the medical field, in particular through scholarships and other grants. It will also organize and/or support seminars and conferences.
About Rhenman & Partners
Rhenman & Partners Asset Management, founded in 2008, is a Stockholm-based investment management company focusing on two niche funds: Rhenman Healthcare Equity L/S, founded in June 2009, and Rhenman Global Opportunities L/S, founded in August 2016. Assets under management amount to approximately 6 billion SEK. Investment Teams of both Funds are in their investment processes supported by renowned Advisory Boards, including professors and experts with many years of market experience and extensive networks around the world.
Tags: